David A. Smelson, PsyD, professor of psychiatry, discusses the challenges of adapting the “MISSION” – Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking – model developed by UMMS for addiction treatment to care for an entire family.
An article about Massachusetts officials seeking permission from the federal government to limit the number of medicines that would be covered by MassHealth, the state Medicaid program, references a plan to work with UMMS to develop a “rigorous review process” to set coverage for new drugs that are guaranteed clinically proven and effective.
Barry N. Feldman, PhD, assistant professor of psychiatry, explains the psychological stress that first responders experience.
Mark Klempner, MD, executive vice chancellor for MassBiologics of UMass Medical School and professor of medicine, explains how scientists at MassBiologics are developing a pre-exposure prophylaxis that prevents tick-transmitted Lyme disease infection, a breakthrough that could lead to seasonal prevention against the most common tick-borne infection in North America.
Dennis Dimitri, MD, vice chair and clinical professor of family medicine & community health, explains how physicians balance prescribing opioids for short-term, acute pain, and reducing the risk of addiction for chronic pain.
Changes to the UMMS nursing curriculum, including the addition of addiction education programs, is referenced in a story about opioids. Jill Terrien, PhD, ANP-BC, assistant professor in the Graduate School of Nursing, was interviewed for the story.
An article about a new RNAi therapy coming to clinic recounts RNAi’s initial discovery by Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine and distinguished professor in the RNA Therapeutics Institute, more than 20 years ago.
UMMS will evaluate a $2.1 million grant given to the Franklin County Probate and Family Court for the purpose of addressing the “impact of opioid, other substance use, and co-occurring disorders on families in rural western Massachusetts.” The program is based on a similar evidence-based model developed by UMMS called “MISSION” – Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking – which has been implemented in other Massachusetts court systems.
Heather C. Forkey, MD, the Joy McCann Professor and associate professor of pediatrics, is quoted in a story exploring how childhood trauma can negatively affect a child’s emotional well-being, but also worsen their mental and physical health, and even alter their DNA.
Mark Klempner, MD, executive vice chancellor for MassBiologics of UMass Medical School and professor of medicine, talks about the first product—a gene therapy for Parkinson’s disease— to be manufactured at the Fall River facility.
Andrew Walter Zimmerman, MD, clinical professor of pediatrics, comments on a new study which found that 17 percent of children with autism are calmer and more communicative than usual when they have a fever.
UMMS is leading the charge to improve the way medical schools train students and providers fight opioid abuse, according to a WCVB-TV report that aired on Sept. 13 during a live, hour-long “Matter of Fact: State of Addiction” special. Kevin O’Day, MD, SOM ’16; Maggie Donovan, DNP, nurse practitioner and UMMS alum; Melissa Fischer, MD, MEd, professor of medicine, associate dean for undergraduate education, curriculum innovation and the Interpersonal Center for Experiential Learning and Simulation; and Jill Terrien, PhD, ANP-BC, assistant professor in the Graduate School of Nursing, were quoted in the story.
Jay G. Fong, MD, assistant professor of pediatrics, and Thomas M. Shields, MD, assistant professor of pediatrics, are quoted in a story about a local woman living with Crohn’s disease.
Brendan O’Leary, executive vice chancellor for Innovation and Business Development, is quoted in an op-ed about the talent UMMS has attracted to Worcester and the valuable intellectual property that talent has developed. The article also mentions start-up ventures and programs by Anastasia Khvorova, PhD, professor in the RNA Therapeutics Institute; Guangping Gao, PhD, the Penelope Booth Rockwell Professor in Biomedical Research, professor of microbiology & physiological systems, and director of the Horae Gene Therapy Center; Celia Schiffer, PhD, professor of biochemistry & molecular pharmacology; Phil Zamore, PhD, Howard Hughes Medical Institute investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, chair and professor of the RNA Therapeutics Institute; Michael Green, MD, PhD, Howard Hughes Medical Institute Investigator, the Lambi and Sarah Adams Chair in Genetic Research and chair and professor of molecular, cell & cancer biology; and Christian Mueller, associate professor of pediatrics.
Jonathan Kay, MD, professor of medicine, is quoted in an article about new recommendations on the use of biosimilars for rheumatologic diseases.
Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine and distinguished professor of molecular medicine and cell biology, comments on the promise of RNAi-based therapeutics.
Casey Sherman’s new book The Ice Bucket Challenge: Pete Frates and the Fight against ALS references the ALS Cellucci Fund at UMass Medical School and includes remarks from ALS researcher John Landers, PhD, professor of neurology.
Judson A. Brewer, MD, PhD, associate professor of medicine, is quoted in a story about integrative medicine about how meditation can be a valuable tool for doctors addressing psychological conditions such as anxiety, depression and addiction.
An editorial about the transformation of the Worcester economy from manufacturing to innovation references UMass Medical School.